Literature DB >> 12220642

Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850 induces its dissociation from myosin.

Guillermo Velasco1, Chris Armstrong, Nick Morrice, Sheelagh Frame, Philip Cohen.   

Abstract

Rho kinase is known to control smooth muscle contractility by phosphorylating the 110 kDa myosin-targetting subunit (MYPT1) of the myosin-associated form of protein phosphatase 1 (PP1M). Phosphorylation of MYPT1 at Thr695 has previously been reported to inhibit the catalytic activity of PP1. Here, we show that the phosphorylation of Thr850 by Rho kinase dissociates PP1M from myosin, providing a second mechanism by which myosin phosphatase activity is inhibited.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220642     DOI: 10.1016/s0014-5793(02)03175-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  86 in total

Review 1.  The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.

Authors:  Rachel S Knipe; Andrew M Tager; James K Liao
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

2.  p116Rip targets myosin phosphatase to the actin cytoskeleton and is essential for RhoA/ROCK-regulated neuritogenesis.

Authors:  Jacqueline Mulder; Aafke Ariaens; Dick van den Boomen; Wouter H Moolenaar
Journal:  Mol Biol Cell       Date:  2004-10-06       Impact factor: 4.138

Review 3.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 4.  A role for the Ca(2+)-dependent tyrosine kinase Pyk2 in tonic depolarization-induced vascular smooth muscle contraction.

Authors:  Ryan D Mills; Mitsuo Mita; Michael P Walsh
Journal:  J Muscle Res Cell Motil       Date:  2015-07-07       Impact factor: 2.698

5.  Regulation of myosin II dynamics by phosphorylation and dephosphorylation of its light chain in epithelial cells.

Authors:  Toshiyuki Watanabe; Hiroshi Hosoya; Shigenobu Yonemura
Journal:  Mol Biol Cell       Date:  2006-12-06       Impact factor: 4.138

Review 6.  Rho kinase (ROCK) inhibitors.

Authors:  James K Liao; Minoru Seto; Kensuke Noma
Journal:  J Cardiovasc Pharmacol       Date:  2007-07       Impact factor: 3.105

7.  Phytoestrogen genistein protects against endothelial barrier dysfunction in vascular endothelial cells through PKA-mediated suppression of RhoA signaling.

Authors:  Zhenquan Jia; Wei Zhen; Pon Velayutham Anandh Babu; Dongmin Liu
Journal:  Endocrinology       Date:  2012-12-18       Impact factor: 4.736

8.  Role of calcium-independent phospholipase A2beta in high glucose-induced activation of RhoA, Rho kinase, and CPI-17 in cultured vascular smooth muscle cells and vascular smooth muscle hypercontractility in diabetic animals.

Authors:  Zhongwen Xie; Ming C Gong; Wen Su; Dongping Xie; John Turk; Zhenheng Guo
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

9.  Ca2+ sensitization pathways accessed by cholinergic neurotransmission in the murine gastric fundus.

Authors:  Bhupal P Bhetwal; Kenton M Sanders; Changlong An; Danielle M Trappanese; Robert S Moreland; Brian A Perrino
Journal:  J Physiol       Date:  2013-04-22       Impact factor: 5.182

Review 10.  Cyclic stretch, reactive oxygen species, and vascular remodeling.

Authors:  Konstantin G Birukov
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.